Filing Details

Accession Number:
0001104659-24-077713
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-07-03 14:33:15
Reporting Period:
2024-07-02
Accepted Time:
2024-07-03 14:33:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604191 Entero Therapeutics Inc. ENTO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1559509 James Sapirstein C/O Entero Therapeutics, Inc
777 Yamato Road, Suite 502
Boca Raton FL 33431
Chairman And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-07-02 1,289 $1.07 35,816 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
  2. The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $1.05 - $1.16, inclusive. The Reporting Person undertakes to provide Entero Therapeutics, Inc. ("Entero"), any security holder of Entero, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forthin this footnote to this Form 4.
  3. Includes unvested RSUs.